Hisamitsu Aims To Increase Profit By 30 Percent In Five Years
This article was originally published in PharmAsia News
Executive Summary
Japanese transdermal therapeutic patch maker Hisamitsu announced a five year mid-term plan to increase group business profit by 33.7 percent to ¥43.5 billion by 2014. The sales will mainly come from major product Salonpas, a pain relief patch series, which is planned to grow by 40 percent in market share. Hisamitsu also forecasts 30 percent growth in the athlete's foot remedy market. (Click here for more - Japanese language